Questions or comments about this article may be directed to Emily C. O’Brien, PhD, at Emily.email@example.com. She is an Assistant Professor at Duke Clinical Research Institute, Durham, NC.
Shreyansh Shah, MD, is Assistant Professor, Department of Neurology, Duke University Hospital, Durham, NC.
Ying Xian, MD PhD, is Associate Professor, Department of Neurology, Duke University Hospital; and Duke Clinical Research Institute, Durham, NC.
DaiWai M. Olson, PhD RN, is Professor, University of Texas Southwestern, Dallas, TX.
Gregg C. Fonarow, MD, is Professor, Division of Cardiology, UCLA Medical Center, Los Angeles, CA.
Eric E. Smith, MD MPH, is Associate Professor, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Lesley Maisch, BA, is a PROSPER Patient Investigator (therefore, she is not affiliated with a particular research institution).
This study was supported by AHRQ PROSPER (ClinicalTrials.gov no. NCT02146274).
Y.X. received research funding to Duke Clinical Research Institute from the American Heart Association, Daiichi Sankyo, Janssen Pharmaceuticals, and Genentech. D.M.O. is Editor in Chief at the Journal of Neuroscience Nursing. G.C.F. received grant support from the Patient-Centered Outcomes Research Institute and is a consultant to Bayer and Janssen, a member of GWTG-Stroke Steering Committee, and an employee of UC Regents who hold a patent on an endovascular device. The remaining authors declare no conflicts of interest.